Approval · Notice of Compliance 5915 · 2004
METASTRON: Notice of Compliance 5915
Issued November 26, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5915
- Date
- November 26, 2004
- Company
- Amersham Health Inc.Mississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change in manufacturing process
- Therapeutic class
- Therapeutic pharmaceutical
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| METASTRON | Not yet assigned | — |
Medicinal ingredients
- STRONTIUM CHLORIDE SR 89 37 MBQ per ML